Company / Total Assets
Beta Bionics, Inc. Total Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$328.7M
FY2025
5-year range
$110.0M / $328.7M
FY2023-FY2025
Trend
+119.7%
vs FY2024
Sector context
#149 of 161
Health Care
What the data says
Among 161 Health Care companies, Beta Bionics, Inc. is in the bottom 7% for total assets. Improved from $110M to $329M over the past 2 years.
Based on SEC 10-K filings.
$329M in FY2025.
Improved from $110M to $329M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 161This company $328.7M Sector average $14.8B
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2025, total assets increased 119.7% year-over-year.
- Ranks #149 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $328.7M | +119.7% |
| FY2024 | $149.6M | +36.0% |
| FY2023 | $110.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026